Mativ reported a 69% increase in sales to $660.1 million, driven by the merger and 6% constant currency organic sales growth. However, the company experienced a GAAP loss of $2.5 million, with a GAAP EPS of $0.04, due to significant expenses related to the Neenah merger integration. Adjusted EPS was $0.56, and Adjusted EBITDA increased by 30% on a comparable basis.
Sales increased 69% to $660.1 million, reflecting the benefit of the merger.
GAAP Income was $2.5 million, and GAAP EPS was $0.04, including significant merger integration expenses.
Adjusted EPS was $0.56, and Adjusted EBITDA was $92.4 million, up 30% on a comparable basis.
Approximately $5 million in cost synergies were realized in 2022, with an additional $25 million expected in 2023.
The company expects an incremental $25 million of synergy delivery in 2023. Visibility remains limited due to macroeconomic and geopolitical risks.
Analyze how earnings announcements historically affect stock price performance